World Hemophilia Day

New Post Public Reply Private Reply Replies (0) Message Board
ziffytech07
229
World Hemophilia Day is held every year on 17th April 2020 to raise international awareness on hemophilia and other blood disorders. The event is held annually on the 17th of April on the birthday of Frank Schnabel, the founder of the World Federation of Hemophilia.

World Federation of Hemophilia started in 1963, celebrates the advances made in treatment as well as raise awareness and highlight the issues related to the care of hemophilia or other blood disorders to the general public. It educates hemophiliac about disease management and lobbies for enhanced medical treatment. The organization has over 113 members and is recognized by the WHO.

The theme of World Hemophilia Day 2020 is “Get+involved” to ask everyone to help the World Federation of Hemophilia with its theme “treatment for all” both at the global and community level. The World Federation of Hemophilia would like everyone to get involved from patients, their family members, and their caretakers to corporate partners, volunteers, and people who support their National member organization to increase knowledge about different inherited blood disorders and the need to improve patient care around the world.

With the present COVD-19 threat many events have been canceled the World Federation of Hemophilia is encouraging people to move the celebration to the community online. Participants are encouraged to write their stories, post about their experiences on social media, and share the posters and other material with your community.

In India, various events are generally organized in different states across the country by the Indian Hemophilia Foundation in partnership with the Ministry of Health and Family Welfare. Usually, on this day medical facilities are provided to the needy, and awareness about hemophilia is increased through various events and programs.

What is hemophilia?

Hemophilia is an inherited blood disorder where the blood does not clot properly. This can lead to spontaneous bleeding and excessive bleeding after an injury or surgery. Your blood contains blood-clotting proteins that help to stop bleeding. People with the disorder contain lower levels of factor VIII (factor 8) or factor IX (factor 9). The lower the level of blood clotting protein will increase the probability of bleeding leading to serious health problems. There are two types of hemophilia:-

Hemophilia A is more common, caused by low levels of factor VIII
Hemophilia B occurs in around 20% of cases and is caused by lower levels of factor IX.
The symptoms of hemophilia can vary from mild to severe. People with severe hemophilia can bleed for no reason or have “spontaneous bleeding”. In children, the symptoms may occur when the child is 2. Common symptoms of hemophilia include excessive bleeding from cuts or injury, several large bruises, painful or swollen joints, blood in stool or urine, and nose bleeds.

Most forms of hemophilia are inherited and are caused by a genetic defect. Acquired hemophilia is a rare condition.

Only 20000 patients are registered under the Hemophilia Federation of India, over 1.5 lakh are not registered until diagnosed. It is estimated over 80% of Indians with hemophilia and other blood disorders remain undiagnosed. India has over 2 lakh cases and is estimated to have the second-highest number of global patients with Hemophilia A.

There is no known cure for hemophilia. If the condition remains undiagnosed repeated bleeding into joints and muscles can lead to disorders such as arthritis, permanent bone deformity, synovitis, and muscle atrophy. Diagnostic centers throughout the country can help with early diagnosis of the disorder. There are various treatment options to help patients lead a more full life.

Visit us: https://www.ziffytech.com/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Updated Category News Views 6

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Continue Reading
Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 5

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 4

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
Red Banyan Earns Top Honors in Florida for 2026

Updated Category News Views 6

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 5

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 5

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading
OrthoAtlanta Expands with Dr. Smith's Expertise Hire

Updated Category News Views 4

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Continue Reading
2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 7

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
American Savings Bank IPO Hits NYSE: $129M Raised

Updated Category News Views 8

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 6

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading

Top 5 Most Recently Viewed Articles

Strategic Boost for Inseego as George Mulhern Joins Board

Updated Category News Views 140

Inseego Welcomes George Mulhern to Its Board of Directors Inseego Corp. (Nasdaq: INSG) is thrilled to announce the appointment of George Mulhern, a distinguished leader in the wireless technology sector, to its Board of Directors. With a profound background in developing and steering wireless tech companies, Mr. Mulhern has most recently held the position of Senior Vice...

Continue Reading
Economic Outlook Raises Concerns of Inflation Under Trump

Updated Category News Views 128

Increased Economic Concerns with Trump's Return Recent findings reveal that economists are increasingly worried about the potential return of former President Donald Trump and its effects on inflation and federal deficits. Survey Findings on Inflation and Economic Policies A survey conducted by a group of economists indicates a majority foresee higher inflation and...

Continue Reading
Join the Class Action Against Rocket Pharmaceuticals Today

Updated Category News Views 134

Join the Class Action Against Rocket Pharmaceuticals Investors are being called to participate in a class action lawsuit concerning Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT). This lawsuit is aimed at recovering losses incurred by shareholders due to alleged securities fraud that impacted the company's financial standing during a specified timeframe. Understanding the...

Continue Reading
Nipocalimab Receives Priority Review from U.S. FDA for gMG

Updated Category News Views 297

Nipocalimab Secures U.S. FDA Priority Review Status Johnson & Johnson (NYSE: JNJ) has exciting news regarding its investigational drug, Nipocalimab. The U.S. Food and Drug Administration (FDA) has granted Priority Review designation for Nisocalimab as a treatment for generalized myasthenia gravis (gMG) in patients with specific autoantibodies. This important milestone...

Continue Reading
Navigating the Canadian Multifamily Landscape: Supply and Demand

Updated Category News Views 89

Understanding Canada's Multifamily Market Trends In recent times, the Canadian multifamily housing market has exhibited some intriguing trends, particularly concerning rent growth and vacancy rates. As highlighted in the latest report from Yardi Canada, the market showcases a scenario where rent growth is slowing, while vacancies remain low. This situation reflects the...

Continue Reading